The “primary” antiphospholipid syndrome: major clinical and serological features

RA ASHERSON, MA KHAMASHTA, J Ordi-Ros… - Medicine, 1989 - journals.lww.com
ASHERSON, RONALD AMD, FACP, FCP,(SA) 1; KHAMASHTA, MUNTHER AMD 1; ORDI-
ROS, JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …

DNase 1 and systemic lupus erythematosus

FM Valle, E Balada, J Ordi-Ros, M Vilardell-Tarres - Autoimmunity reviews, 2008 - Elsevier
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology with a
complex genetic basis that includes many susceptibility genes on multiple chromosomes. As …

Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity

E Balada, J OrdiRos… - Reviews in medical …, 2009 - Wiley Online Library
Eight per cent of the human genome is derived from the integration of retroviral sequences
that were incorporated in our DNA more than 25 million years ago. Although some of these …

Implication of human endogenous retroviruses in the development of autoimmune diseases

…, M Vilardell-Tarrés, J Ordi-Ros - International reviews of …, 2010 - Taylor & Francis
Retroviruses can exist in an endogenous form, in which viral sequences are integrated into
the human germ line and are vertically transmitted in a Mendelian fashion. Human …

Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients

JL Vianna, MA Khamashta, J Ordi-Ros, J Font… - The American journal of …, 1994 - Elsevier
Abstract purpose: To determine whether the features of the antiphospholipid syndrome
(APS) are in any way influenced by the presence or absence of systemic lupus …

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

J Cortés‐Hernández, J OrdiRos, F Paredes… - …, 2002 - academic.oup.com
Objective. Our aim was to assess the outcome of pregnancy in a cohort of patients with SLE
and to evaluate clinical and laboratory markers for fetal outcome and maternal flares …

Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial

J Ordi-Ros, L Sáez-Comet… - Annals of internal …, 2019 - acpjournals.org
Background: The potential role of new oral anticoagulants in antiphospholipid antibody
syndrome (APS) remains uncertain. Objective: To determine whether rivaroxaban is …

miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis

…, ML Felip, M Vidal, J Ordi-Ros - Nephrology Dialysis …, 2015 - academic.oup.com
Background Despite overall improvement in prognosis, 10–30% of patients with lupus
nephritis (LN) will develop end-stage renal disease. To date, renal biopsy is still the 'gold …

[HTML][HTML] Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study

…, M Calaza, E Endreffy, R Pullmann, J Ordi-Ros… - Arthritis research & …, 2009 - Springer
Introduction We aimed to replicate association of newly identified systemic lupus
erythematosus (SLE) loci. Methods We selected the most associated SNP in 10 SLE loci …

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

L Ziporen, I Goldberg, M Arad, M Hojnik, J Ordi-Ros… - Lupus, 1996 - journals.sagepub.com
Objective. To examine the potential immunologic mechanism and involvement of antiphos
pholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphos …